The present invention relates to pharmaceutically acceptable compounds, including
acylguanidine compounds, and methods of treatment and pharmaceutical compositions
that utilize or comprise one or more such compounds. Compounds of the invention
are particularly useful for the treatment or prophylaxis of neurological injury
and neurodegenerative disorders.